Table 5 Predictors of HTN control at six months among participants enrolled in integrated HTN/HIV care (N = 1015)

Age groups (years)

 18–29

1

1

 30–39

0.360

0.054 – 2.368

0.280

 40–49

0.311

0.048—1.994

0.219

 50 and older

0.393

0.061 – 2.512

0.275

Sex

 Female

1

1

 Male

0.961

0.731 – 1.263

0.919

ART duration

  < 2 years

1

1

 2—5yrs

2.346

1.185 – 4.646

2.294^a

 5—10yrs

2.612

1.365 – 4.999

2.848^a

  > 10yrs

3.590

1.835 – 7.025

4.352^a

Baseline CD4 count categories

  < 50

1

1

  50—< 100

1.306

0.676 – 2.524

1.190

  100—< 200

1.303

0.791 – 2.145

1.269

   > 200

1.166

0.759 – 1.791

1.172

HIV viral load

  >  = 1000

1

1

  < 1000

3.532

1.161 – 10.745

3.221^a

BMI(Kg/m.²)

 Underweight (< 19.0)

1

1

 Normal weight (19.0—< 25.0)

1.126

0.615 – 2.062

1.158

 Overweight (25.0—< 30.0)

1.096

0.597 – 2.012

1.108

 Obese (> = 30.0)

0.995

0.536 – 1.846

1.057

Baseline ART regimen

 AZT-3TC-NVP

1

1

 AZT-3TC-EFV

0.888

0.616 – 1.281

0.976

 TDF-3TC-NVP

1.384

0.858 – 2.230

1.613

 TDF-3TC-EFV

0.947

0.674 – 1.329

1.400

 Other

0.599

0.335 – 1.072

1.075

 No family history of HTN

1

1

 Positive family history of HTN

1.083

0.771 – 1.521

1.069

 No history of stroke

1

1

 Positive History of stroke

0.836

0.401 – 1.743

0.763

 No history of CKD

1

1

 Positive History of CKD

1.420

0.412 – 4.888

1.369

Diabetes Mellitus

 Non-diabetic

1

1

 Diabetic

1.103

0.774 – 1.573

1.098

 Non-smoker

1

1

Smoker

1.693

1.051 – 2.727

1.755